CAMBRIDGE, Mass., Aug. 6, 2014 (GLOBE NEWSWIRE) -- Radius Health (Nasdaq: RDUS ) announced today that it will release its second quarter 2014 financial results on Tuesday, August 12, 2014.
In connection with the earnings release, Radius Health will host a conference call and live audio webcast at 8.30 a.m. ET on Tuesday, August 12, 2014 to discuss the results.
Conference Call Information:
Date : Tuesday, August 12, 2014
Time : 8.30 a.m. ET
Domestic Dial-in Number: 1-201-493-6725
International Dial-in Number: 1-877-705-6003
Live webcast: http://public.viavid.com/index.php?id=110542
For those unable to participate in the conference call or webcast, a replay will be available beginning August 12, 2014 at 11:30 a.m. ET until September 12, 2014 at 11:59 p.m. ET. To access the replay, dial 1-877-870-5176 or 1-858-384-5517. The replay passcode is 13588795.
A live audio webcast of the call will also be available on the Investors section of the Company's website, www.radiuspharm.com . A webcast replay will be available for 30 days on the Radius website, www.radiuspharm.com . The full text of the announcement and financial results will also be available on the Company's website.
About Radius Health
Radius Health, Inc. is a science-driven biopharmaceutical company developing novel differentiated therapeutics for patients with advanced osteoporosis as well as other serious endocrine-mediated diseases. The company's lead development candidate is abaloparatide (BA058) for subcutaneous injection, currently in Phase 3 development for the reduction of fracture risk in postmenopausal women with severe osteoporosis. The Radius clinical portfolio also includes an abaloparatide transdermal patch for osteoporosis and RAD1901 for estrogen-driven breast cancer brain metastases. www.radiuspharm.com
Investor Relations Barbara Ryan FTI Consulting Managing Director 212-850-5679 Media Relations Kimberly Ha FTI Consulting Senior Director 212-850-5612